Theodoros Tsakiridis

7PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursRadiation therapyMolecular targetsInstruments and techniques
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 04, 2026
HER2-specific synthetic antigen receptor T cell therapy synergizes with radiotherapy to provide improved antitumor efficacy in non-small cell lung cancer.

Olga-Demetra Biziotis, Christopher M Silvestri, Allyson E Moore

|Jul 31, 2025
ACLY inhibition promotes tumour immunity and suppresses liver cancer.

Jaya Gautam, Jianhan Wu, James S V Lally

|Jul 28, 2025
In Reply to Onal et al. Primary Analysis of (NCT03380806) a Phase II Randomized Trial of Stereotactic Body Radiotherapy Boost Versus Conventional Fractionation External Beam Radiotherapy Boost in Unfavorable-Intermediate and High-Risk Prostate Cancer.

Andre Gouveia, Ian Dayes, Theodoros Tsakiridis

|Sep 08, 2023
The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy.

Amr Ali, Bassem Mekhaeil, Olga-Demetra Biziotis

|Aug 16, 2023
Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non-small cell lung cancer (NSCLC) through inhibition of HIF-1α.

Olga-Demetra Biziotis, Evangelia Evelyn Tsakiridis, Amr Ali

|Feb 16, 2022
Salvage radiotherapy following HiFU: An institutional series and literature review.

Aruz Mesci, Mohammad Gouran-Savadkoohi, Derek Ribeiro

Pageof 2

Frequent Collaborators

3 joint publications

Amr Ali

3 joint publications

Jonathan L Bramson

3 joint publications

Gregory R Steinberg

2 joint publications

Olga-Demetra Biziotis